19例耐多药结核病患者的药学监护  

Pharmaceutical Care in 19 Cases of MDR-TB Patients from the China Global Fund TB Program

作　　者：魏润新[1] 李敏[2] 

机构地区：[1]泰州市人民医院,泰州225300 [2]南京医科大学药学院,南京210029

出　　处：《药学与临床研究》2014年第2期163-167,共5页Pharmaceutical and Clinical Research

基　　金：2012年中国全球基金耐多药结核病实施项目

摘　　要：对19例耐多药结核病患者进行药学监护,提高患者的依从性和治疗效果。19例患者有12例出现了不同程度的不良反应;6例使用卷曲霉素的患者中有4例出现低血钾;7例使用对氨基水杨酸的患者中有5例出现腹泻;2例使用环丝氨酸的患者出现了由药物引起的精神症状。药师分别进行了一般药学监护和重点药学监护。Pharmaceutical care was carried out in 19 cases of multidrug-resistant tuberculosis（MDRTB） patients to improve treatment effect.In the 19 patients,12 cases had different degree of ADR;In 6 patients using capreomycin,4 cases had hypokalemia;In 7 patients using aminosalicylic acid,5 cases had diarrhea;The 2 patients using cycloserine had psychiatric symptoms caused by drugs.Pharmacists carried out general or intensive pharmaceutical care for these patients.In conclusion,pharmaceutical care can improve patient compliance and reduce the incidence of ADR,which should become an important part of MDR-TB treatment.

关 键 词：耐多药结核 药学监护 不良反应 依从性 

分 类 号：R969.3[医药卫生—药理学]